Envestnet Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-207
Closed -$21K 2671
2014
Q4
$21K Sell
207
-176
-46% -$13.7K ﹤0.01% 1742
2014
Q3
$25K Sell
383
-29
-7% -$1.91K ﹤0.01% 1796
2014
Q2
$29K Hold
412
﹤0.01% 1643
2014
Q1
$30K Sell
412
-19
-4% -$1.42K ﹤0.01% 1548
2013
Q4
$30K Buy
431
+137
+47% +$8.87K ﹤0.01% 1394
2013
Q3
$19K Buy
294
+67
+30% +$4.05K ﹤0.01% 1506
2013
Q2
$11K Buy
+227
New +$11.2K ﹤0.01% 1644

Envestnet Asset Management's CBST Position: Q1 2015 in Review

Envestnet Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 207 shares — an estimated $21K sold.

Envestnet Asset Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $30K in Q1 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Envestnet Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Envestnet Asset Management sold 207 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $21K.
  • Envestnet Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Envestnet Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $30K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Envestnet Asset Management's 13F filing for Q1 2015, filed 15 May 2015.